Featured Publications
Access challenges to opioid use disorder treatment among individuals experiencing homelessness: Voices from the streets
Hsu M, Jung O, Kwan L, Jegede O, Martin B, Malhotra A, Suzuki J. Access challenges to opioid use disorder treatment among individuals experiencing homelessness: Voices from the streets. Journal Of Substance Use And Addiction Treatment 2023, 157: 209216. PMID: 37981243, DOI: 10.1016/j.josat.2023.209216.Peer-Reviewed Original ResearchOpioid use disorderSocioeconomic statusUse disordersCOVID-19 pandemicBuprenorphine/naloxoneActive substance useUse disorder treatmentPercent of participantsActive prescriptionMOUD accessSublingual buprenorphineOUD treatmentTreatment gapTreatment accessMOUDDisorder treatmentBuprenorphineAdverse effectsSubstance useVulnerable populationsIndividual-level factorsMedicationsAccess challengesWhite participantsDisorders
2022
Community based buprenorphine micro-induction in the context of methadone maintenance treatment and fentanyl – Case report
Kaliamurthy S, Jegede O, Hermes G. Community based buprenorphine micro-induction in the context of methadone maintenance treatment and fentanyl – Case report. Journal Of Addictive Diseases 2022, 41: 175-180. PMID: 35377273, DOI: 10.1080/10550887.2022.2051985.Peer-Reviewed Case Reports and Technical NotesConceptsFull opioid agonistsOpioid use disorderFentanyl useOpioid agonistsUse disordersMethadone doseCommunity-based methadone maintenance programIllicit fentanyl useCharacteristics of patientsMethadone maintenance treatmentMethadone maintenance programMaintenance treatmentOutpatient clinicTime of inductionOutpatient settingCommunity clinicsBuprenorphinePatientsMore cliniciansAgonistsDisordersClinicCliniciansDoseWithdrawal